Impact of Tranexamic Acid on Chondrocytes and Osteogenically Differentiated Human Mesenchymal Stromal Cells (hMSCs) In Vitro
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Journal of Clinical Medicine 2020, 9(12), 3880; https://doi.org/10.3390/jcm9123880
- Ereignis
-
Veröffentlichung
- (wo)
-
Würzburg
- (wer)
-
Universität Würzburg
- (wann)
-
2021
- Urheber
-
Wagenbrenner, Mike
Heinz, Tizian
Horas, Konstantin
Jakuscheit, Axel
Arnholdt, Joerg
Mayer-Wagner, Susanne
Rudert, Maximilian
Holzapfel, Boris M.
Weißenberger, Manuel
- DOI
-
10.3390/jcm9123880
- URN
-
urn:nbn:de:bvb:20-opus-219410
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:22 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wagenbrenner, Mike
- Heinz, Tizian
- Horas, Konstantin
- Jakuscheit, Axel
- Arnholdt, Joerg
- Mayer-Wagner, Susanne
- Rudert, Maximilian
- Holzapfel, Boris M.
- Weißenberger, Manuel
- Universität Würzburg
Entstanden
- 2021
Ähnliche Objekte (12)
BM-MSCs differentiated to chondrocytes for treatment of full-thickness cartilage defect of the knee
Galectin-1 and galectin-3 expression in equine mesenchymal stromal cells (MSCs), synovial fibroblasts and chondrocytes, and the effect of inflammation on MSC motility
Short exposure to tranexamic acid does not affect, in vitro, the viability of human chondrocytes
Optimizing conditions for labeling of mesenchymal stromal cells (MSCs) with gold nanoparticles: a prerequisite for in vivo tracking of MSCs
Pharmaceutical induction of ApoE secretion by multipotent mesenchymal stromal cells (MSCs)
Emerging role of mesenchymal stem/stromal cells (MSCs) and MSCs-derived exosomes in bone- and joint-associated musculoskeletal disorders: a new frontier
Correction to: Optimizing conditions for labeling of mesenchymal stromal cells (MSCs) with gold nanoparticles: a prerequisite for in vivo tracking of MSCs
Response of human chondrocytes and mesenchymal stromal cells to a decellularized human dermis
Connexin 43 regulates intercellular mitochondrial transfer from human mesenchymal stromal cells to chondrocytes
Mesenchymal stromal cells (MSCs) and their exosome in acute liver failure (ALF): a comprehensive review
The role of MSCs and CAR-MSCs in cellular immunotherapy
MSCs in Space: Mesenchymal Stromal Cell Therapeutics as Enabling Technology for Long-Distance Manned Space Travel
BM-MSCs differentiated to chondrocytes for treatment of full-thickness cartilage defect of the knee
Galectin-1 and galectin-3 expression in equine mesenchymal stromal cells (MSCs), synovial fibroblasts and chondrocytes, and the effect of inflammation on MSC motility
Short exposure to tranexamic acid does not affect, in vitro, the viability of human chondrocytes
Optimizing conditions for labeling of mesenchymal stromal cells (MSCs) with gold nanoparticles: a prerequisite for in vivo tracking of MSCs
Pharmaceutical induction of ApoE secretion by multipotent mesenchymal stromal cells (MSCs)
Emerging role of mesenchymal stem/stromal cells (MSCs) and MSCs-derived exosomes in bone- and joint-associated musculoskeletal disorders: a new frontier
Correction to: Optimizing conditions for labeling of mesenchymal stromal cells (MSCs) with gold nanoparticles: a prerequisite for in vivo tracking of MSCs
Response of human chondrocytes and mesenchymal stromal cells to a decellularized human dermis
Connexin 43 regulates intercellular mitochondrial transfer from human mesenchymal stromal cells to chondrocytes
Mesenchymal stromal cells (MSCs) and their exosome in acute liver failure (ALF): a comprehensive review
The role of MSCs and CAR-MSCs in cellular immunotherapy
MSCs in Space: Mesenchymal Stromal Cell Therapeutics as Enabling Technology for Long-Distance Manned Space Travel
BM-MSCs differentiated to chondrocytes for treatment of full-thickness cartilage defect of the knee
Galectin-1 and galectin-3 expression in equine mesenchymal stromal cells (MSCs), synovial fibroblasts and chondrocytes, and the effect of inflammation on MSC motility
Short exposure to tranexamic acid does not affect, in vitro, the viability of human chondrocytes
Optimizing conditions for labeling of mesenchymal stromal cells (MSCs) with gold nanoparticles: a prerequisite for in vivo tracking of MSCs
Pharmaceutical induction of ApoE secretion by multipotent mesenchymal stromal cells (MSCs)
Emerging role of mesenchymal stem/stromal cells (MSCs) and MSCs-derived exosomes in bone- and joint-associated musculoskeletal disorders: a new frontier
Correction to: Optimizing conditions for labeling of mesenchymal stromal cells (MSCs) with gold nanoparticles: a prerequisite for in vivo tracking of MSCs
Response of human chondrocytes and mesenchymal stromal cells to a decellularized human dermis
Connexin 43 regulates intercellular mitochondrial transfer from human mesenchymal stromal cells to chondrocytes
Mesenchymal stromal cells (MSCs) and their exosome in acute liver failure (ALF): a comprehensive review
The role of MSCs and CAR-MSCs in cellular immunotherapy